Home LiteratureArticle Details
PMID: 15175489 Published · ppublish English Comparative Study Journal Article

Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK.

Quality & safety in health care ·Vol. 13 ·No. 3 ·2004-06-00 ·Pages 191-7

McElduff P, Lyratzopoulos G, Edwards R, Heller RF, Shekelle P, Roland M

Abstract

To estimate the total health gain from improving the quality of care among patients with cardiovascular disease in line with the quality indicator targets in the new contract for general practitioners (GPs) in the UK. Statistical modelling, applying population impact measures to estimate cardiovascular health gains from achieving treatment targets in the GP contract, taking into account current levels of treatment and control. Number of events prevented in the population over 5 years applied to a national general practice population of 10,000. The greatest health gain in those aged 45-84 years would come from reaching cholesterol reduction targets. This could prevent 15 events in people with coronary heart disease, seven events in those with a history of stroke, and seven events in those with diabetes. Achieving blood pressure control targets in hypertensive patients without the above conditions could prevent 15 cardiovascular events, with further benefits from reducing blood pressure in patients with high blood pressure and coronary heart disease, stroke, or diabetes. Achieving other targets would have smaller impacts because high levels of care are already being achieved or because of the low prevalence of conditions or associated event risk. It is possible to quantify the health gain to a practice population of achieving quality targets such as those set in the new GP contract. The amount of health gain is sensitive to current quality of care, prevalence of conditions, and risk factors, and to the size of change anticipated. Nevertheless, it appears that significant health gains could result from achieving the proposed quality targets.

MeSH Terms
Aged Aged, 80 and over Antihypertensive Agents/therapeutic use Aspirin/therapeutic use Cardiovascular Diseases/economics,epidemiology,prevention & control Cholesterol/blood Female Humans Hypertension/economics,epidemiology,therapy Influenza Vaccines/administration & dosage Male Middle Aged Models, Econometric Physician Incentive Plans Prevalence Primary Health Care/economics,standards Quality Assurance, Health Care/economics Quality Indicators, Health Care Reimbursement, Incentive United Kingdom/epidemiology
Chemicals
Antihypertensive Agents Influenza Vaccines Cholesterol Aspirin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
McElduff P
Evidence for Population Health Unit, School of Epidemiology and Health Sciences, Medical School, University of Manchester, Manchester M13 9PT, UK. [email protected]
Lyratzopoulos G
Edwards R
Heller R F
Shekelle P
Roland M
References (24)
24 references, click to expand
  1. Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues.
    Int J Qual Health Care. 2000 Apr;12(2):133-42 PMID: 10830670
  2. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    N Engl J Med. 1999 Sep 2;341(10):709-17 PMID: 10471456
  3. Impact of payment method on behaviour of primary care physicians: a systematic review.
    J Health Serv Res Policy. 2001 Jan;6(1):44-55 PMID: 11219360
  4. Coronary artery disease as the cause of incident heart failure in the population.
    Eur Heart J. 2001 Feb;22(3):228-36 PMID: 11161934
  5. Beta-blockers in congestive heart failure. A Bayesian meta-analysis.
    Ann Intern Med. 2001 Apr 3;134(7):550-60 PMID: 11281737
  6. Prognostic factors for influenza-associated hospitalization and death during an epidemic.
    Epidemiol Infect. 2001 Apr;126(2):261-8 PMID: 11357897
  7. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study.
    Lancet. 2001 Aug 11;358(9280):439-44 PMID: 11513906
  8. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans.
    J Infect Dis. 2001 Sep 15;184(6):665-70 PMID: 11517426
  9. Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand.
    Qual Health Care. 2001 Sep;10(3):152-8 PMID: 11533422
  10. Identifying predictors of high quality care in English general practice: observational study.
    BMJ. 2001 Oct 6;323(7316):784-7 PMID: 11588082
  11. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.
    Vaccine. 2002 Mar 15;20(13-14):1831-6 PMID: 11906772
  12. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses.
    Int J Epidemiol. 2002 Feb;31(1):72-6 PMID: 11914297
  13. Commentary: relative treatment effects are consistent across the spectrum of underlying risks...usually.
    Int J Epidemiol. 2002 Feb;31(1):76-7 PMID: 11914298
  14. Mortality associated with influenza and respiratory syncytial virus in the United States.
    JAMA. 2003 Jan 8;289(2):179-86 PMID: 12517228
  15. Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register.
    J Public Health Med. 2003 Mar;25(1):29-35 PMID: 12669915
  16. Implementing guidelines in primary care: can population impact measures help?
    BMC Public Health. 2003 Jan 23;3:7 PMID: 12542840
  17. Variations in process and outcomes of diabetes care by socio-economic status in Salford, UK.
    Diabetologia. 2003 Jun;46(6):750-9 PMID: 12764577
  18. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.
    Lancet. 1990 Mar 31;335(8692):765-74 PMID: 1969518
  19. Cardiovascular disease risk profiles.
    Am Heart J. 1991 Jan;121(1 Pt 2):293-8 PMID: 1985385
  20. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989.
    Int J Epidemiol. 1993 Apr;22(2):334-40 PMID: 8505193
  21. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study.
    BMJ. 1994 Feb 5;308(6925):363-6 PMID: 8124143
  22. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
    BMJ. 1994 Feb 5;308(6925):367-72 PMID: 8043072
  23. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database.
    Epidemiol Infect. 1995 Dec;115(3):581-9 PMID: 8557090
  24. Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group.
    Am J Cardiol. 2000 Jan 15;85(2):187-92 PMID: 10955375
Article Info
Journal
Quality & safety in health care
Abbr.
Qual Saf Health Care
ISSN
1475-3898
Published
2004-06-00
Pages
191-7
Language
English
Region
England
NLM ID
101136980
PMCID
PMC1743844
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]